跳至主要内容
临床试验/NCT02100293
NCT02100293已完成不适用

Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2013年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
84
试验地点
1
主要终点
onset time of rocuronium

研究概览

简要总结

This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose rocuronium, intubation condition and surgical condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-75 yr American Society of Anesthesiologists physical status 1 or 2, BMI of 20-24.9 kg/m2 scheduled for elective laryngeal microsurgery

排除标准

  • severe respiratory or cardiac disease hepatic or renal function impairment neuromuscular disease on medications affecting neuromuscular function with known allergy to the drugs

研究组 & 干预措施

standard dose rocuronium group

Active Comparator

pretreatment of saline 100ml and rocuronium 0.6 mg/kg

干预措施: saline (Drug)

low dose rocuronium group

Active Comparator

pretreatment of saline 100ml and rocuronium 0.45 mg/kg

干预措施: saline (Drug)

low dose rocuronium plus magnesium group

Active Comparator

pretreatment of magnesium sulfate 30 mg/kg and rocuronium 0.45 mg/kg

干预措施: magnesium sulfate 30 mg/kg (Drug)

结局指标

主要结局

onset time of rocuronium

时间窗: from injection of rocuronium to T1 suppression more than 95% up to 10 minutes

from injection of rocuronium to T1 suppression more than 95% up to 10 minutes

次要结局

  • maximal suppression time and duration of rocuronium(time from the injection of rocuronium to T1 maximal suppression time and reversal of T1 25% up to 1 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验